The NMDA antagonist ketamine and the 5-HT agonist psilocybin produce dissociable effects on structural encoding of emotional face expressions Read More > July 27, 2012
Replication of Ketamine's Antidepressant Efficacy in Bipolar Depression: A Randomized Controlled Add-On Trial Read More > January 31, 2012
A preliminary naturalistic study of low-dose ketamine for depression and suicide ideation in the emergency department Read More > September 1, 2011
Ketamine plus imipramine treatment induces antidepressant-like behavior and increases CREB and BDNF protein levels and PKA and PKC phosphorylation in rat brain Read More > August 1, 2011
Pilot Study of Psilocybin Treatment for Anxiety in Patients With Advanced-Stage Cancer Read More > January 3, 2011
The neurobiology of psychedelic drugs: implications for the treatment of mood disorders Read More > September 10, 2010
A Randomized Add-on Trial of an N-methyl-D-aspartate Antagonist in Treatment-Resistant Bipolar Depression Read More > August 9, 2010
Gaddum and LSD: the birth and growth of experimental and clinical neuropharmacology research on 5-HT in the UK Read More > January 29, 2009
Effects of ayahuasca on psychometric measures of anxiety, panic-like and hopelessness in Santo Daime members Read More > July 27, 2007
